Trial Profile
The Vascular Effects of Carvedilol Controlle Release (CR) + Lisinopril Versus Lisinopril + Hydrochlorothiazide (HCTZ) in Abdominally Obese Hypertensive Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Carvedilol (Primary) ; Hydrochlorothiazide; Lisinopril
- Indications Hypertension
- Focus Biomarker; Pharmacodynamics
- 01 Feb 2012 Results published in the Journal of Clinical Hypertension (Greenwich).
- 10 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.